Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
17 September 2024 - EA120
Boosting M. abscessus drug discovery: engineering high-throughput screening with a double-reporter strain
Tânia Silva, Gabriel S. Oliveira, Clara M. Bento, António Pombinho, Rita Reis, Kevin Van Calster, Linda De Vooght, André Maia, Paul Cos, Maria Salomé Gomes
30 April 2024 - E1274
The platform trial in COVID-19 priming and boosting (PICOBOO): the immunogenicity, reactogenicity, and safety of three approved COVID-19 booster vaccines in immunocompetent adults
Charlie Mcleod, Michael Dymock, Katie Flanagan, Plebanski Magdalena, Helen Marshall, Marie Estcourt, Jessica Ramsay, Ushma Wadia, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Suellen Nicholson, Saul Faust, Thornton Ruth, Mckenzie Anne, Snelling Tom, Richmond Peter,
30 April 2024 - LB053
Modelling the impact of the Autumn 2022 and Spring 2023 COVID-19 booster vaccine campaigns in the UK
Diana Mendes, Sheeja Manchira Krishnan, Esme O'Brien, Thomas Padgett, Cale Harrison, David Strain, Andrea Manca, Andrew Ustianowski, Rebecca Butfield, Elizabeth Hamsom, Charlie Reynard, Jingyan Yang
30 April 2024 - LB029
Divergent performance of bivalent BA.5 and monovalent XBB.1.5 COVID-19 vaccines given as annual booster
Marianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, Giulia Dowgier, Rebecca Penn, Theo Sanderson, Phoebe Stevenson-Leggett, James Bazire, Ruth Harvey, George Kassiotis, Steve Gamblin, Nicola Lewis, Bryan Williams, Charles Swanton, Sonia Gandhi, Edward Carr, Mary Y. Wu, David L.V. Bauer, Emma Wall
30 April 2024 - LB022
COSAN boosts colistin's bactericidal power against Gram-negative nosocomial pathogens
Andromeda Celeste Gomez Camacho, Daniel Yero, Xavier Daura, Rosario Núñez, Isidre Gibert,
30 April 2024 - LB036
Open-label study to evaluate the safety and immunogenicity of an XBB.1.5 (Omicron subvariant) CoV-2 rS vaccine booster in previously mRNA COVID-19 vaccinated participants
Katia Alves, Karen Kotloff, R. Scott Mcclelland, Alex Kouassi, Katherine Smith, Muneer Kaba, Joy Nelson, Vivek Shinde, Raburn M. Mallory, Fernando Noriega
30 April 2024 - LB046
Immunogenicity and reactogenicity of fractional vs full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, Phase 4 clinical trial in Brazil
Marco Antônio Puga, Roberto Oliveira, Patricia Vieira, Vivek Charu, Haley Hedlin, Di Lu, Amy Zhang, Blake Shaw, Joelle Rosser, Jessica Seidman, Alice Carter, Farah Qamar, Stephen Luby, Denise Garrett, Julio Croda,
30 April 2024 - LB051
Boosted antibody responses after sequential vaccination with PCV13 and PPSV23 in patients with moderate to severe plaque psoriasis under immunosuppressive therapy: a prospective trail
Lorena Helmer, Lukas Van De Sand, Thea Wojtakowski, Mona Otte, Oliver Witzke, Wiebke Sondermann, Adalbert Krawczyk, Monika Lindemann
29 April 2024 - O1114
Boosting antibody neutralisation breadth against emerging Omicron subvariants with monovalent mRNA, bivalent mRNA or Nuvaxovid vaccine as 2nd booster: interim results from Phase D of PRIBIVAC, a randomised clinical trial
Xuan Ying Poh, Aileen Ying Yan Yeoh, Shirley Yun Yan Mah, Jean-Marc Chavatte, Daniel Rui Xiang Lim, Suma Rao, Po Ying Chia, Tau Hong Lee, Sapna P. Sadarangani, Ray Jun Hao Lin, Yi Qing Chin, Lisa Fong Poh Ng, Laurent Renia, Raymond Lin, David Chien Boon Lye, Lin-Fa Wang, Chee Wah Tan, Barnaby E. Young,
29 April 2024 - E1117
Vancomycin efficacy boosted by an enzymatic cocktail adjunct therapy in prosthetic joint infections: in vitro and in vivo demonstration of synergy
Randy Buzisa Mbuku, Hervé Poilvache, Loïc Maigret, Olivier Cornu, Françoise Van Bambeke
28 April 2024 - P2548
Nano boost: enhancing antibacterial efficacy of ceftriaxone with magnesium oxide nanoparticles to tackle antimicrobial resistance
Qaiser Akram, Ahsan Naeem, Rizwan Saeed
28 April 2024 - O0524
Immunogenicity, reactogenicity and safety of a second booster with BNT162b2 or full-dose mRNA-1273: a randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1-AGED Part B)
Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, Kristin Greve-Isdahl Mohn, Antonio-José Carcas-Sansuan, Esperanza Romero Rodriguez, José Moltó, Itziar Vergara Mitxeltorena, Tobias Welte, Birutė Zablockienė, Murat Akova, Ullrich Bethe, Sarah Heringer, Jon Salmanton-García, Julia Jeck, Lea Tischmann, Marouan Zarrouk, Arnd Cüppers, Lena Biehl, Jan Grothe, Sibylle C. Mellinghoff, Julia A. Nacov, Julia M. Neuhann, Rosanne Sprute, Jesús Frías-Iniesta, Riya Negi, Colette Marie Gaillard, Gurvin Saini, Alejandro García León, Patrick W. G. Mallon, Christine Lammens, Ann Hotterbeekx, Katherine Loens, Surbhi Malhotra-Kumar, Herman Goossens, Samir Kumar-Singh, Franz König, Martin Posch, Philipp Koehler, Oliver A. Cornely
27 April 2024 - P0536
COVID-19 mRNA vaccines may also boost immunity to seasonal coronaviruses and influenza
Vennila Gopal, Paul Anantharajah Tambyah, Hung Chew Wong, Kah Man Lai, Yee Joo Tan, Ooiean Teng, Amy Quek, Raymond Seet, Chunke Chen, Chris Mok
27 April 2024 - P0505
Evaluation of humoral immune responses against SARS-CoV-2 variants after receiving booster doses
Yu-Cheng Cheng, Si-Man Ieong, Yi Yao, Tai-Ling Chao, Wang-Huei Sheng, Sui-Yuan Chang,
27 April 2024 - P0397
Usage of oral contraceptives among healthcare workers: impact on COVID-19 booster vaccine immunogenicity
Isabell Wagenhäuser, Julia Reusch, Juliane Mees, Lukas B. Krone, Thiên-Trí Lâm, Alexandra Schubert-Unkmeir, Anna Frey, Lars Dölken, Oliver Kurzai, Stefan Frantz, Alexander Gabel, Manuel Krone, Nils Petri
27 April 2024 - P0516
Longitudinal anti-SARS-CoV-2 antibody responses reveal cross-reactive boosting following vaccination
Dylan George, Kathleen Angell, Lauren Longacre, Janet Williamson, Bailey Barcal, Julie Carstens, Andrew Schnaubelt, David Brett-Major, Mara Jana Broadhurst
27 April 2024 - P0518
Concomitant vaccination uptake of the COVID-19 booster and influenza vaccine in the United States during the 2021/22 and 2022/23 seasons
Aung Pone Myint, Joshua Nealon, Robertus Van Aalst, Clotilde El Guerche-Séblain
27 April 2024 - P0401
Bivalent Omicron BA1 vaccine booster increases the breadth and potency of memory-B and T cell response and protects against emerging SARS-CoV-2 variants
Lok Bahadur Shrestha, , Kerrie Sandgren, Katie Tungatt, Stuart Turville, Nicodemus Tedla, Andrew Lloyd, Rowena Bull, Anthony Cunningham
27 April 2024 - P0464
Anti-RBD IgG titres after a primary vaccination course with BNT162b2 and after a third booster dose with a first-generation m-RNA vaccine in a cohort of people living with HIV
Anna Maria Azzini, Valentina Lando, Assunta Sartor, Marco Bertoldi, Anna Erbogasto, Enrico Gibbin, Alessandro Castelli, Giulia De Luca, Alessandro Visentin, Maria Elena De Rui, Chiara Perlini, Matteo Morra, Daniele Fasan, Chiara Zanchi, Filippo Cioli Puviani, Francesco Luca, Elda Righi, Evelina Tacconelli
27 April 2024 - P0390
Immunogenicity of a single booster dose of Soberana Plus (FINLAY-FR-1A) vaccine in adults with different previous history of COVID-19 vaccination
Igor Stoma, Katsiaryna Korsak, Evgenii Voropaev, Olga Osipkina, Aleksey Kovalev
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.